Nyxoah SA — Form 6-K Summary
Business context and reporting period
Nyxoah SA furnished this Form 6-K on May 16, 2023, reporting unaudited financial and operating results for the first quarter of 2023. The filing includes a press release and a First Quarter 2023 report as Exhibits 99.1 and 99.2.
Financial metrics
The provided filing text does not include the underlying quarterly financial tables or clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics. These details are contained in the referenced Exhibit 99.2, which is not included in the supplied text.
Material changes versus the prior comparable period
The filing announces the availability of first-quarter 2023 results but does not provide comparative financial figures or describe material changes versus the first quarter of 2022 in the supplied text.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the supplied Form 6-K text. The filing states that Exhibit 99.1 is furnished and generally not deemed filed under Section 18 of the Exchange Act, while Exhibit 99.2 is incorporated by reference into specified registration statements.
Investor verification items
- Verify first-quarter 2023 revenue, operating expenses, net loss, cash burn, and ending cash in Exhibit 99.2.
- Verify any year-over-year operating and financial changes and management’s stated outlook.
- Review debt, liquidity, financing requirements, and going-concern or other risk disclosures.
- Confirm the scope and terms of any material business, regulatory, clinical, or commercial updates in Exhibits 99.1 and 99.2.